RARγ is overexpressed in human colorectal cancer [38], cholangiocarcinoma [39], hepatocellular cancer [40], ovarian cancer [41], pancreatic ductal adenocarcinoma [42,43], and renal cell cancer [44]. Here, RARG is linked to cholangiocarcinoma.